{"id":"NCT01161420","sponsor":"Inspire Medical Systems, Inc.","briefTitle":"Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)","officialTitle":"Effects of the Inspire Implantable Nerve Stimulation System on Obstructive Sleep Apnea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2013-03","completion":"2017-04","firstPosted":"2010-07-13","resultsPosted":"2014-12-15","lastUpdate":"2017-08-25"},"enrollment":929,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Obstructive Sleep Apnea"],"interventions":[{"type":"DEVICE","name":"Inspire Upper Airway Stimulation System","otherNames":["Inspire","UAS","Inspire Therapy"]}],"arms":[{"label":"Inspire Therapy","type":"EXPERIMENTAL"}],"summary":"The purpose of this clinical trial is to demonstrate long-term safety and efficacy of the Inspire system. The Inspire Upper Airway Stimulation (UAS) therapy is intended to treat moderate-to-severe obstructive sleep apnea by improving airway patency through stimulation of the hypoglossal nerve. Study objectives include demonstrating that the Inspire system improves key indices of sleep apnea in a pre-specified percentage of patients.","primaryOutcome":{"measure":"Apnea Hypopnea Index","timeFrame":"12 months","effectByArm":[{"arm":"Inspire Therapy","deltaMin":66,"sd":null}],"pValues":[]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":22,"countries":["United States","Belgium","France","Germany","Netherlands"]},"refs":{"pmids":["33647987","33295277","32970962","24401051"],"seeAlso":["http://www.inspiresleep.com"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":126},"commonTop":["Discomfort due to electrical stimulation","Events specifically related to an incision","Post-operative discomfort independent of any surgical incision","Temporary tongue weakness","Tongue abrasion"]}}